These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34123844)

  • 1. IP-10 (CXCL10) Can Trigger Emergence of Dormant Breast Cancer Cells in a Metastatic Liver Microenvironment.
    Clark AM; Heusey HL; Griffith LG; Lauffenburger DA; Wells A
    Front Oncol; 2021; 11():676135. PubMed ID: 34123844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures.
    Clark AM; Kumar MP; Wheeler SE; Young CL; Venkataramanan R; Stolz DB; Griffith LG; Lauffenburger DA; Wells A
    Mol Cell Proteomics; 2018 Apr; 17(4):619-630. PubMed ID: 29353230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Complexity of the Metastatic Niche Ex Vivo.
    Clark AM
    Methods Mol Biol; 2021; 2258():221-239. PubMed ID: 33340364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Tumor Cell Dormancy in an Ex Vivo Liver Metastatic Niche.
    McDonald JC; Clark AM
    Methods Mol Biol; 2024; 2811():37-53. PubMed ID: 39037648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins attenuate outgrowth of breast cancer metastases.
    Beckwitt CH; Clark AM; Ma B; Whaley D; Oltvai ZN; Wells A
    Br J Cancer; 2018 Oct; 119(9):1094-1105. PubMed ID: 30401978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro system to study tumor dormancy and the switch to metastatic growth.
    Barkan D; Green JE
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21860375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
    Soejima K; Rollins BJ
    J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition.
    Taylor DP; Clark A; Wheeler S; Wells A
    Breast Cancer Res Treat; 2014 Apr; 144(3):551-60. PubMed ID: 24610032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties.
    Clark AM; Wheeler SE; Young CL; Stockdale L; Shepard Neiman J; Zhao W; Stolz DB; Venkataramanan R; Lauffenburger D; Griffith L; Wells A
    Lab Chip; 2016 Dec; 17(1):156-168. PubMed ID: 27910972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and In Vivo Systems to Study Tumor Dormancy and the Transition to Overt Metastases Induced by the Fibrotic Milieu.
    Bernshtein KS; Barkan D
    Methods Mol Biol; 2024; 2811():27-35. PubMed ID: 39037647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro hyaluronic acid hydrogel based platform to model dormancy in brain metastatic breast cancer cells.
    Narkhede AA; Crenshaw JH; Crossman DK; Shevde LA; Rao SS
    Acta Biomater; 2020 Apr; 107():65-77. PubMed ID: 32119920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.
    Barkan D; Kleinman H; Simmons JL; Asmussen H; Kamaraju AK; Hoenorhoff MJ; Liu ZY; Costes SV; Cho EH; Lockett S; Khanna C; Chambers AF; Green JE
    Cancer Res; 2008 Aug; 68(15):6241-50. PubMed ID: 18676848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
    Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in breast cancer metastatic dormancy: Tumor suppressing or tumor promoting functions?
    Flynn AB; Schiemann WP
    J Cancer Metastasis Treat; 2019; 5():. PubMed ID: 31431926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and Hepatic Tumor Microenvironment Associated Dormancy.
    Akkoc Y; Gozuacik D
    J Gastrointest Cancer; 2021 Dec; 52(4):1277-1293. PubMed ID: 34921672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
    Marlow R; Dontu G
    Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The osteoblast in regulation of tumor cell dormancy and bone metastasis.
    Zarrer J; Taipaleenmäki H
    J Bone Oncol; 2024 Apr; 45():100597. PubMed ID: 38550395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.
    Marsden CG; Wright MJ; Carrier L; Moroz K; Rowan BG
    PLoS One; 2012; 7(11):e47587. PubMed ID: 23173031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression predicts dormant metastatic breast cancer cell phenotype.
    Ren Q; Khoo WH; Corr AP; Phan TG; Croucher PI; Stewart SA
    Breast Cancer Res; 2022 Jan; 24(1):10. PubMed ID: 35093137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Innate Immune System in Cancer Dormancy and Relapse.
    Chernosky NM; Tamagno I
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.